Consensus Gland Pharma Limited

Stocks

GLAND

INE068V01023

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:07 2026-10-27 EDT			5-day change	1st Jan Change
2,960.30 ^INR	+4.09%		+0.86%	+71.91%

10-08	Nomura Adjusts Gland Pharma's Price Target to INR3,750 From INR3,330, Keeps at Buy	MT
10-04	Indian shares open higher as Fed-hike fears, oil prices ease; financials lead	RE

Evolution of the Average Target: Gland Pharma Limited

Evolution of the Target Price: Gland Pharma Limited

Changes in Analyst Recommendations: Gland Pharma Limited

c7f0d7cc54.ScUoZDVtVVAUibnhDEIlO0NZWkNyUGmgjNPgIvJ-n8A.DahZVQAqFghR5siFaQtDXxEWbCE8MS7hx5ikfZQT_a0Z8VwNf1o5IX7f1g~064a99daa32d71ab6acb0edcae9f4be7

Analysts' recommendations: Gland Pharma Limited

10-08	Nomura Adjusts Gland Pharma's Price Target to INR3,750 From INR3,330, Keeps at Buy	MT
08-12	Nomura Adjusts Gland Pharma's Price Target to INR3,330 From INR2,390, Keeps at Buy	MT
08-11	Jefferies Upgrades Gland Pharma to Buy From Hold, Adjusts Price Target to INR3,350 From INR2,080	MT
05-18	Kotak Securities Upgrades Gland Pharma to Add From Reduce; Price Target is INR2,075	MT
05-18	Nomura Adjusts Gland Pharma's Price Target to INR2,390 from INR2,000, Keeps at Buy	MT
05-18	Jefferies Adjusts Gland Pharma's Price Target to INR2,080 from INR1,720, Keeps at Hold	MT
01-30	Nomura Upgrades Gland Pharma to Buy From Neutral, Keeps Price Target at INR2,000	MT
01-29	Elara Securities Upgrades Gland Pharma to Buy from Accumulate, Price Target is INR2,225	MT
01-29	Jefferies Adjusts Gland Pharma's Price Target to INR1,720 From INR1,690, Keeps at Hold	MT
11-04	Jefferies Adjusts Gland Pharma's Price Target to INR2,050 From INR1,970, Keeps at Hold	MT
11-04	Nomura Adjusts Gland Pharma's Price Target to INR2,000 From INR2,010, Keeps at Neutral	MT
25-08-07	Nomura Adjusts Gland Pharma's Price Target to INR2,010 From INR1,570, Keeps at Neutral	MT
25-08-06	Jefferies Upgrades Gland Pharma to Hold From Underperform, Adjusts Price Target to INR1,970 From INR1,350	MT
25-02-07	Nomura Adjusts Gland Pharma's Price Target to INR1,570 From INR1,790, Keeps at Neutral	MT
25-02-04	Jefferies Adjusts Gland Pharma's Price Target to INR1,350 From INR1,630, Keeps at Underperform	MT
25-01-21	Nomura Upgrades Gland Pharma to Neutral From Reduce, Adjusts Price Target to INR1,790 From INR1,800	MT
24-11-06	Nomura Adjusts Gland Pharma's Price Target to INR1,800 From INR1,819, Keeps at Reduce	MT
24-11-05	Jefferies Adjusts Gland Pharma's Price Target to INR1,840 From INR2,180, Keeps at Hold	MT
24-08-08	Nomura Downgrades Gland Pharma to Reduce From Neutral, Adjusts Price Target to INR1,819 From INR1,570	MT
24-08-07	Jefferies Downgrades Gland Pharma to Hold From Buy, Adjusts Price Target to INR2,180 From INR2,240	MT
24-05-23	Jefferies Adjusts Gland Pharma's Price Target to INR2,240 From INR2,400, Keeps at Buy	MT
24-02-15	Jefferies Adjusts Gland Pharma’s Price Target to INR2,400 From INR2,250, Keeps at Buy	MT
23-11-08	Nomura Upgrades Gland Pharma to Neutral From Reduce, Adjusts Price Target to INR1,570 From INR1,157	MT
23-11-07	Jefferies Adjusts Gland Pharma's Price Target to INR1,800 From INR1,640, Keeps at Buy	MT
23-05-22	Nomura Downgrades Gland Pharma to Reduce From Neutral, Adjusts Price Target to INR1,157 From INR1,524	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	GLAND PHARMA LIMITED					+4.24%
	ELI LILLY AND COMPANY					+4.27%
	JOHNSON & JOHNSON					+4.92%
	ABBVIE INC.					-0.68%
	ROCHE HOLDING AG					-2.56%
	MERCK & CO., INC.					+13.62%
	NOVARTIS AG					-2.85%
	ASTRAZENECA PLC					+22.47%
	AMGEN INC.					-10.64%
	GILEAD SCIENCES, INC.					+0.95%
	Average					+3.37%
	Weighted average by Cap.					+3.54%